Literature DB >> 12921809

Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure.

Denis Mariano-Goulart1, Marie-Claude Eberlé, Vincent Boudousq, Azadeh Hejazi-Moughari, Christophe Piot, Charles Caderas de Kerleau, Régis Verdier, Marie-Luce Barge, Frédéric Comte, Nicole Bressot, Michel Rossi, Pierre-Olivier Kotzki.   

Abstract

This study sought to investigate whether the presence of right ventricular systolic dysfunction with pre-existing left ventricular systolic dysfunction is associated with higher plasma brain natriuretic peptide (BNP) levels, compared with patients with isolated left ventricular dysfunction. Eighty-five patients referred for evaluation of isotopic ventricular function were prospectively included in the study. Left (LVEF) and right (RVEF) ventricular ejection fractions were evaluated by gated blood pool scintigraphy and compared with plasma BNP levels. BNP correlated negatively with LVEF, except in patients with ischaemic heart disease (P=0.09) and in patients with LVEF<40% (P=0.11). In contrast, BNP levels correlated negatively with RVEF for all subgroups. Among patients with RVEF<40%, no significant BNP difference was found between patients with or without additional left ventricular systolic dysfunction (P=0.51). Among patients with LVEF<40%, plasma BNP levels were significantly higher in patients with RVEF<40% than in patients with RVEF>/=40% (P=0.004) whereas age, renal function, clinical findings, ventricular volumes, LVEF or medication were not significantly different. In conclusion, an important increase in BNP levels in patients with left ventricular systolic dysfunction should be considered by cardiologists as an indication of high risk of right ventricular dysfunction and should justify further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921809     DOI: 10.1016/s1388-9842(03)00041-2

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  10 in total

1.  Effects of cardiac resynchronization therapy on right ventricular function during rest and exercise, as assessed by radionuclide angiography, and on NT-proBNP levels.

Authors:  Cinzia Valzania; Mauro Biffi; Rachele Bonfiglioli; Francesco Fallani; Cristian Martignani; Igor Diemberger; Matteo Ziacchi; Jessica Frisoni; Luciana Tomasi; Stefano Fanti; Claudio Rapezzi; Giuseppe Boriani
Journal:  J Nucl Cardiol       Date:  2017-06-30       Impact factor: 5.952

Review 2.  Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.

Authors:  A Palazzuoli; M Gallotta; I Quatrini; R Nuti
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

Review 3.  Devices in heart failure: potential methods for device-based monitoring of congestive heart failure.

Authors:  Shahzeb M Munir; Roberta C Bogaev; Ed Sobash; K J Shankar; Sreedevi Gondi; Igor V Stupin; Jillian Robertson; M Alan Brewer; S Ward Casscells; Reynolds M Delgado; Amany Ahmed
Journal:  Tex Heart Inst J       Date:  2008

4.  Comparison between brain natriuretic peptide and calcitonin gene-related peptide in children with dilated cardiomyopathy and controls.

Authors:  Noor Mohammad Noori; Alireza Teimouri; Iraj Shahramian
Journal:  Niger Med J       Date:  2017 Jan-Feb

5.  Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.

Authors:  Yan Deng; Weifeng Wu; Shenglan Guo; Yuming Chen; Chang Liu; Xingcui Gao; Bin Wei
Journal:  Respir Res       Date:  2017-03-24

6.  Sex-dependent right ventricular hypertrophic gene changes after methamphetamine treatment in mice.

Authors:  Hicham Labazi; Margaret Nilsen; Margaret R MacLean
Journal:  Eur J Pharmacol       Date:  2021-03-28       Impact factor: 4.432

7.  Circulating sLR11 levels predict severity of pulmonary hypertension due to left heart disease.

Authors:  Yusuke Joki; Hakuoh Konishi; Hiroyuki Ebinuma; Kiyoshi Takasu; Tohru Minamino
Journal:  PLoS One       Date:  2021-12-29       Impact factor: 3.240

8.  Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.

Authors:  Nobuyuki Kanno; Yasutomo Hori; Yuichi Hidaka; Seishiro Chikazawa; Kazutaka Kanai; Fumio Hoshi; Naoyuki Itoh
Journal:  J Vet Med Sci       Date:  2015-11-26       Impact factor: 1.267

9.  Comparison between procalcitonin, brain natriuretic peptide, and uric acid in children with cardiomyopathy and controls.

Authors:  Noor Mohammad Noori; Maziar Mahjoubifard; Iraj Shahramian; Alireza Teimouri; Alireza Jahangirifard
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

10.  Brain Natriuretic Peptide Levels in Acute Inferior Myocardial Infarction.

Authors:  Tarik Yildirim; Seda Elcim Yildirim; Meryem Aktoz; Armagan Altun
Journal:  J Clin Med Res       Date:  2018-01-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.